Chapter 10 Nerve excitability studies: past, present, future?

Supplements to Clinical Neurophysiology

Volumn 57, Issue C, 2004, Pages 85-90

  Bostock, Hugh ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTION POTENTIAL; ELECTROSTIMULATION; HISTORY; HUMAN; METHODOLOGY; NERVE CONDUCTION; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; REVIEW;

ACTION POTENTIALS; ELECTRIC STIMULATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NERVOUS SYSTEM DISEASES; NEURAL CONDUCTION;

EID: 25144459916     PISSN: 1567424X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-424X(09)70346-0     Document Type: Article

References (39)

1. Bostock H., Sharief M.K., Reid G., and Murray N.M. Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain 118 (1994) 217-225
2. Bostock H., Cikurel K., and Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 21 (1998) 137-158
3. Burke D., Kiernan M.C., and Bostock H. Excitability of human axons. Clin. Neurophysiol. 112 (2001) 1575-1585
4. Cappelen-Smith C., Kuwabara S., Lin C.S., Mogyoros I., and Burke D. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Ann. Neurol. 48 (2000) 826-832
5. Cappelen-Smith C., Kuwabara S., Lin C.S., Mogyoros I., and Burke D. Membrane properties in chronic inflammatory demyelinating polyneuropathy. Brain 124 (2001) 2439-2447
6. Cappelen-Smith C., Kuwabara S., Lin C.S., and Burke D. Abnormalities of axonal excitability are not generalized in early multifocal motor neuropathy. Muscle Nerve 26 (2002) 769-776
7. Cappelen-Smith C., Lin C.S., Kuwabara S., and Burke D. Conduction block during and after ischaemia in chronic inflammatory demyelinating polyneuropathy. Brain 125 (2002) 1850-1858
8. Cappelen-Smith C., Lin C.S., and Burke D. Activity-dependent hyperpolarization and impulse conduction in motor axons in patients with carpal tunnel syndrome. Brain 126 (2003) 1001-1008
9. Dumitru D. Electrodiagnostic medicine (1995), Hanley and Belfus, Philadelphia
10. Fowler C.J. Early history of nerve conduction studies and electromyography. In: Osselton J.W. (Ed). Clinical Neurophysiology (1995), Butterworth-Heinemann, Oxford 45-49
11. Hill A.V. Excitation and accommodation in nerve. Proc. R. Soc. Lond. B. Biol. Sci. 119 (1936) 305-355
12. Hodgkin A.L., and Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. (Lond.) 117 (1952) 500-544
13. Horn S., Quasthoff S., Grafe P., Bostock H., Renner R., and Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve 19 (1996) 1268-1275
14. Kaji R., Bostock H., Kohara N., Murase N., Kimura J., and Shibasaki H. Activity-dependent conduction block in multifocal motor neuropathy. Brain 123 (2000) 1602-1611
15. Kanai K., Kuwabara S., Arai K., Sung J.Y., Ogawara K., and Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 126 (2003) 965-973
16. Kiernan M.C., Mogyoros I., and Burke D. Conduction block in carpal tunnel syndrome. Brain 122 (1999) 933-941
17. Kiernan M.C., Burke D., Andersen K.V., and Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 23 (2000) 399-409
18. Kiernan M.C., Hart I.K., and Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J. Neurol. Neurosurg. Psychiatry 70 (2001) 56-64
19. Kiernan M.C., Lin C.S., Andersen K.V., Murray N.M., and Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle Nerve 24 (2001) 883-892
20. Kiernan M.C., Guglielmi J.M., Kaji R., Murray N.M., and Bostock H. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 125 (2002) 664-675
21. Kiernan M.C., Walters R.J., Andersen K.V., Taube D., Murray N.M., and Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalemia. Brain 125 (2002) 1366-1378
22. Kiernan, M.C., Burke, D. and Bostock, H. Nerve excitability measures: biophysical basis and use in the investigation of peripheral nerve disease, 2004.
23. Kuwabara S., Kanai K., Sung J.Y., Ogawara K., Hattori T., Burke D., and Bostock H. Axonal hyperpolarization associated with acute hypokalemia: multiple excitability measurements as indicators of the membrane potential of human axons. Muscle Nerve 26 (2002) 283-287
24. Kuwabara S., Ogawara K., Harrori T., Suzuki Y., and Hashimoto N. The acute effects of glycemic control on axonal excitability in human diabetic nerves. Intern. Med. 41 (2002) 360-365
25. Kuwabara S., Ogawara K., Sung J.Y., Mori M., Kanai K., Hattori T., Yuki N., Lin C.S., and Burke D. and Bostock, H. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann. Neurol. 52 (2002) 180-187
26. Kuwabara S., Bostock H., Ogawara K., Sung J.Y., Misawa S., Kitano Y., Mizobuchi K., Lin C.S., and Hattori T. Excitability properties of human median axons measured at the motor point. Muscle Nerve 29 (2004) 227-233
27. Lapique L. L'excitabilite en fonction du temps: la chronaxie, sa signification et sa mesure (1926), University DeParis, Paris
28. Lin C.S., Kiernan M.C., Burke D., and Bostock H. Assessment of nerve excitability properties in peripheral nerve disease. In: Kimura J. (Ed). Clinical Neurophysiology of Peripheral Nerve Diseases (2004), Elsevier
29. Maddison P., Newsom-Davis J., and Mills K.R. Strength-duration properties of peripheral nerve in acquired neuromyotonia. Muscle Nerve 22 (1999) 823-830
30. Meulstee J., Darbas A., Van Doorn P.A., Van Briemen L., and Van der Meche F.G. (Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies. J. Neurol. Neurosurg. Psychiatry 62 (1997) 398-400
31. Mogyoros I., Kiernan M.C., and Burke D. Strength-duration properties of sensory and motor axons in carpal tunnel syndrome. Muscle Nerve 20 (1997) 508-510
32. Mogyoros I., Kiernan M.C., Burke D., and Bostock H. Ischemic resistance of cutaneous afferents and motor axons in patients with amyotrophic lateral sclerosis. Muscle Nerve 21 (1998) 1692-1700
33. Nodera H., Bostock H., Kuwabara S., Sakamoto T., Asanuma K., Jia-Ying S., Ogawara K., Hattori N., Hirayama M., Sobue G., and Kaji R. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain 127 (2003) 1-9
34. Purves-Stewart J., and Worster-Drought C. The diagnosis of nervous diseases. 10th Edn. (1952), Edward Arnold, London
35. Quasthoff S., Großkreutz J., Kühn M., Schilling T., and Hanauske A.R. Taxol-cisplatin neuropathy caused by membrane leak and axonal depolarization: an in vivo and in vitro study. J. Neurology 242 6 (1995) S145
36. Ritchie A.R. The electrical diagnosis of peripheral nerve injury. Brain 67 (1944) 314-330
37. Strupp M., Bostock H., Weigl P., Piwernetz K., Renner R., and Grafe P. Is resistance to ischaemia of motor axons in diabetic subjects due to membrane depolarization?. J. Neurol. Sci. 99 (1990) 271-280
38. Sung J.Y., Kuwabara S., Kaji R., Ogawara K., Mori M., Kanai K., Nodera H., Hattori T., and Bostock H. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles. Muscle Nerve 29 (2003) 28-37
39. Weigl P., Bostock H., Franz P., Martius P., Muller W., and Grafe P. Threshold tracking provides a rapid indication of ischaemic resistance in motor axons of diabetic subjects Electroencephalogr. Clin. Neurophysiol. 73 (1989) 369-371